Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

474
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
474
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
Prodrugs01:30

Prodrugs

2.4K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.4K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

676
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
676
Principles of Drug Action01:24

Principles of Drug Action

5.7K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.7K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

402
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
402

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LRP4 is an entry receptor for multiple encephalitic alphaviruses.

Nature communications·2026
Same author

HIF-1α integrates lipogenic FASN and glycolytic GLUT3 to overcome intratumor oxidative and hypoxic stress for colorectal cancer metastasis.

Oncogene·2026
Same author

Perivascular adipose single-cell atlas identifies CD55<sup>+</sup> adipose-derived stem cells as vascular remodeling regulators in atherosclerosis.

Nature communications·2026
Same author

Nitrogen-Doped CeO<sub>2-x</sub> Supports Accelerate Interfacial Water Dissociation at Surface Pt Sites for Durable Industrial Alkaline Hydrogen Evolution.

Angewandte Chemie (International ed. in English)·2026
Same author

Integrative analysis reveals the clinical utility of cancer-associated fibroblast-derived signature, and its implication for young-onset thyroid cancer.

Genes & diseases·2026
Same author

Associations of Chronic Rhinosinusitis and Nasal Polyps With Elevated Venous Thromboembolism Risk: Evidence From the UK Biobank.

Allergy·2026

Related Experiment Video

Updated: May 24, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.3K

Applications of Artificial Intelligence in Drug Repurposing.

Zhaoman Wan1, Xinran Sun2, Yi Li3

  • 1State Key Laboratory of Common Mechanism Research for Major Diseases, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu, 215123, China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|March 6, 2025
PubMed
Summary

Artificial intelligence (AI) accelerates drug repurposing by analyzing large datasets to find new uses for existing medications. This approach reduces development time and costs, offering a more efficient path to market.

Keywords:
artificial intelligencedrug repurposingdrug‐response predictionmachine learning modelspersonalized medicine

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K

Related Experiment Videos

Last Updated: May 24, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.3K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K

Area of Science:

  • Pharmacology
  • Computational Biology
  • Drug Discovery

Background:

  • Drug repurposing offers a cost-effective strategy by leveraging existing drugs' safety profiles.
  • Traditional drug discovery methods are time-consuming and expensive.
  • Artificial intelligence (AI) presents a computationally advantageous alternative for identifying novel therapeutic applications.

Purpose of the Study:

  • To review the role of AI algorithms in drug development and repurposing.
  • To highlight AI's integration with virtual screening for enhanced drug repurposing.
  • To discuss the potential of AI in accelerating the identification of new drug indications.

Main Methods:

  • Analysis of AI algorithms applied to drug development datasets.
  • Integration of AI with virtual screening techniques.
  • Examination of AI's capability in pattern recognition within large-scale biological and chemical data.

Main Results:

  • AI algorithms effectively analyze extensive datasets to identify complex drug response patterns.
  • AI demonstrates significant potential in predicting viable drug repurposing candidates.
  • AI integration with virtual screening enhances the precision and speed of identifying repurposed drugs.

Conclusions:

  • AI significantly enhances drug repurposing efficiency by analyzing complex data and predicting outcomes.
  • Future research should focus on data integration, AI computational efficiency, and personalized medicine applications.
  • AI-driven approaches are crucial for overcoming challenges in modern drug discovery and development.